Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 214

Similar articles for PubMed (Select 12760863)

1.

Genetic and phenotypic variations of a resistant Pseudomonas aeruginosa epidemic clone.

Hocquet D, Bertrand X, Köhler T, Talon D, Plésiat P.

Antimicrob Agents Chemother. 2003 Jun;47(6):1887-94.

2.

Role of efflux pumps: MexAB-OprM and MexXY(-OprA), AmpC cephalosporinase and OprD porin in non-metallo-β-lactamase producing Pseudomonas aeruginosa isolated from cystic fibrosis and burn patients.

Aghazadeh M, Hojabri Z, Mahdian R, Nahaei MR, Rahmati M, Hojabri T, Pirzadeh T, Pajand O.

Infect Genet Evol. 2014 Jun;24:187-92. doi: 10.1016/j.meegid.2014.03.018. Epub 2014 Mar 30.

PMID:
24694825
3.

In vivo emergence of multidrug-resistant mutants of Pseudomonas aeruginosa overexpressing the active efflux system MexA-MexB-OprM.

Ziha-Zarifi I, Llanes C, Köhler T, Pechere JC, Plesiat P.

Antimicrob Agents Chemother. 1999 Feb;43(2):287-91.

4.

Clinical strains of Pseudomonas aeruginosa overproducing MexAB-OprM and MexXY efflux pumps simultaneously.

Llanes C, Hocquet D, Vogne C, Benali-Baitich D, Neuwirth C, Plésiat P.

Antimicrob Agents Chemother. 2004 May;48(5):1797-802.

5.

Multiple genotypic changes in hypersusceptible strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients do not always correlate with the phenotype.

Wolter DJ, Black JA, Lister PD, Hanson ND.

J Antimicrob Chemother. 2009 Aug;64(2):294-300. doi: 10.1093/jac/dkp185. Epub 2009 May 25.

6.

[Carbapenem resistance in Pseudomonas aeruginosa isolates: an example of interaction between different mechanisms].

Santella G, Pollini S, Docquier JD, Almuzara M, Gutkind G, Rossolini GM, Radice M.

Rev Panam Salud Publica. 2011 Dec;30(6):545-8. Spanish.

7.
9.
11.

OprD mutations and inactivation, expression of efflux pumps and AmpC, and metallo-β-lactamases in carbapenem-resistant Pseudomonas aeruginosa isolates from South Korea.

Lee JY, Ko KS.

Int J Antimicrob Agents. 2012 Aug;40(2):168-72. doi: 10.1016/j.ijantimicag.2012.04.004. Epub 2012 May 26.

PMID:
22633564
12.

Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.

Vettoretti L, Plésiat P, Muller C, El Garch F, Phan G, Attrée I, Ducruix A, Llanes C.

Antimicrob Agents Chemother. 2009 May;53(5):1987-97. doi: 10.1128/AAC.01024-08. Epub 2009 Mar 2.

13.
14.

Multidrug resistance associated with mexXY expression in clinical isolates of Pseudomonas aeruginosa from a Texas hospital.

Wolter DJ, Smith-Moland E, Goering RV, Hanson ND, Lister PD.

Diagn Microbiol Infect Dis. 2004 Sep;50(1):43-50.

PMID:
15380277
15.
16.

Mechanisms of carbapenem resistance in non-metallo-beta-lactamase-producing clinical isolates of Pseudomonas aeruginosa from a Tunisian hospital.

Hammami S, Ghozzi R, Burghoffer B, Arlet G, Redjeb S.

Pathol Biol (Paris). 2009 Nov-Dec;57(7-8):530-5. doi: 10.1016/j.patbio.2008.09.001. Epub 2008 Oct 31.

PMID:
18977099
17.

Molecular epidemiology and multidrug resistance mechanisms of Pseudomonas aeruginosa isolates from Bulgarian hospitals.

Vatcheva-Dobrevska R, Mulet X, Ivanov I, Zamorano L, Dobreva E, Velinov T, Kantardjiev T, Oliver A.

Microb Drug Resist. 2013 Oct;19(5):355-61. doi: 10.1089/mdr.2013.0004. Epub 2013 Apr 21.

PMID:
23600605
18.

Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Chinese hospitals.

Wang J, Zhou JY, Qu TT, Shen P, Wei ZQ, Yu YS, Li LJ.

Int J Antimicrob Agents. 2010 May;35(5):486-91. doi: 10.1016/j.ijantimicag.2009.12.014. Epub 2010 Feb 24.

PMID:
20185276
19.
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk